DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Aglepristone
Aglepristone
WSAVA List of Essential Medicines for Cats and Dogs
Pharmaceutical Appendix to the Tariff Schedule 2
Reproductive Endocrinology of the Dog
Non-Surgical Contraception in Female Dogs and Cats
Aglepristone (A-Gle-Pris-Tone) Alizin®, Alizine® Injectable Progesterone Blocker
Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös
Effects of Aglépristone, a Progesterone Receptor Antagonist, Administered
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Page 1 FINLANDS FÖRFATTNINGSSAMLING Utgiven I Helsingfors
Fertility Outcome After Medically Treated Pyometra in Dogs
Stembook 2018.Pdf
Technical Note on Non-Lethal Measures to Eradicate Or Manage Vertebrates Included on the List of IAS of Union Concern
Customs Tariff - Schedule
Wo 2009/120182 A2
Thesis Molecular, Hormonal and Clinical Aspects of Aglepristone In
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Prolonged Interval Before Conception Following Aglepristone-Induced Abortion in Albino Rats
Customs Tariff - Schedule
Top View
Comparative Efficacy of Mifepristone, Cloprostenol and Dinoprost Along
Aglepristone Administration in Mid-Proestrus Reduces the LH Peak but Does Not Prevent Ovulation in the Bitch
Changes in Peripheral Hormone Levels After Mid-Gestation Termination of Pregnancy with Aglepristone in Rats
Lack of in Vitro Effect of Aglepristone on IFN-Γ and IL-4 Production By
Customs Tariff - Schedule Xxi - 1
Receptor Blockers — General Aspects with Respect to Their Use in Domestic
LIST of AUTHORISED/REGISTERED Vmps
Pyometra in the Queen
Cancer in Females: Are Hormones the Culprit?
Progesterone Receptor Isoform Ratio: a Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness Paola A
Practical Use of Hormones in Small Animal Reproduction Uso Clínico De Hormônios Na Repodução De Pequenos Animais
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Changes in Peripheral Hormone Levels After Mid-Gestation Termination of Pregnancy with Aglepristone in Rats
Anti- Gestagens
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Mucometra, Cystic Endometrial Hyperplasia, and Pyometra in the Bitch: Advances in Treatment and Assessment of Future Reproductive Success J
Biological and Clinical Impact of Imbalanced Progesterone Receptor Isoform Ratios in Breast Cancer
Decreased Size of Mammary Tumors Caused by Preoperative Treatment with Aglepristone in Female Domestic Dogs
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Progesterone Receptor Isoform Ratio: a Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness Paola A
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
Pharmaceuticals Appendix
Top 5 Reproduction Concerns in Dogs
Mifepristone
View Consolidated Schedules
Aglepristone) in Small Animal Reproduction
Abbreviation: Y = Yes, FDA = FDA Approved, EU GMP = EDQM Approved
View Public Assessment Report
Lääkeluettelon Aineet, Liite 1
Use of the Progesterone (P4) Receptor Antagonist Aglepristone to Characterize the Role of P4 Withdrawal for Parturition and Placental Release in Cows
Hiperplasia Fibroepitelial Mamaria Felina: Reporte De Un Caso*
Summary of Product Characteristics 1. Name Of